These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12784873)

  • 21. Comparison of glioblastoma (GBM) molecular classification methods.
    Lee E; Yong RL; Paddison P; Zhu J
    Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development.
    Krex D; Mohr B; Appelt H; Schackert HK; Schackert G
    Neurosurgery; 2003 Dec; 53(6):1377-84; discussion 1384. PubMed ID: 14633303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of astrocytic tumor progression.
    Mikkelsen T
    Mol Genet Med; 1993; 3():69-94. PubMed ID: 8220164
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular predictors in glioblastoma: toward personalized therapy.
    Colman H; Aldape K
    Arch Neurol; 2008 Jul; 65(7):877-83. PubMed ID: 18625854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
    Liang Y; Diehn M; Watson N; Bollen AW; Aldape KD; Nicholas MK; Lamborn KR; Berger MS; Botstein D; Brown PO; Israel MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5814-9. PubMed ID: 15827123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.
    Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E
    Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic markers in glioblastoma: prognostic significance and future therapeutic implications.
    Hill C; Hunter SB; Brat DJ
    Adv Anat Pathol; 2003 Jul; 10(4):212-7. PubMed ID: 12826827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular biology and molecular genetics of astrocytic neoplasms.
    Wong AJ; Zoltick PW; Moscatello DK
    Semin Oncol; 1994 Apr; 21(2):139-48. PubMed ID: 8153660
    [No Abstract]   [Full Text] [Related]  

  • 33. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
    Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ
    Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral vector: potential therapeutic for glioblastoma multiforme.
    Manikandan C; Kaushik A; Sen D
    Cancer Gene Ther; 2020 May; 27(5):270-279. PubMed ID: 31316136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of therapeutic targets for glioblastoma by network analysis.
    Friedmann-Morvinski D; Bhargava V; Gupta S; Verma IM; Subramaniam S
    Oncogene; 2016 Feb; 35(5):608-20. PubMed ID: 25961929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and Genomic Alterations in Glioblastoma Multiforme.
    Crespo I; Vital AL; Gonzalez-Tablas M; Patino Mdel C; Otero A; Lopes MC; de Oliveira C; Domingues P; Orfao A; Tabernero MD
    Am J Pathol; 2015 Jul; 185(7):1820-33. PubMed ID: 25976245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genes implicated in glial tumors].
    Sanson M; Marie Y; Huguet S; He J; Hoang-Xuan K
    Morphologie; 2000 Jun; 84(265):51-5. PubMed ID: 11048299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
    Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
    Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.